Moreover, the AR’s value as a drug target is strengthened by the concept that the molecular apocrine BCa and castration-resistant PCa (CRPC) cells share a core AR cistrome and target gene signature linked to cancer cell growth (Malinen et al. 2015). Here, AR is linked to posterior cortical atrophy.